Described herein are variants of H. jecorina CBHI, a Cel7 enzyme. The present invention provides novel cellobiohydrolases that have improved thermostability and reversibility.

An exhaust system (10) for an engine system, the exhaust system (10) comprising a pipe system (12) having at least one input port (15, 16) for receiving exhaust gases from the engine (14) system and at least one output port (18) for venting exhaust gases from the exhaust system (10) wherein the pipe system (12) includes at least two exhaust routes for flow of gases from the one or more input ports...

The device has at least one top hat rail (3) or mounting plate for holding at least one appliance, especially a protective switch attached to two supports (2) at a distance apart on a substructure. The supports and the rail or plate or coupling parts (4) arranged on them have mutual adaptations that form a solid seat with at least one releasable latch (6,9) that holds them together.

A system for propelling a vehicle along an elevated, pneumatic power tube carried by exterior support structure above ground. First and second angles define tracks for the vehicle and extend parallel to the power tube. Undercarriages secured to the vehicle including vehicle support and guidance wheels which are rotatable about axes inclined relative to legs of the angle tracks have a periphery tha...

A method of producing enzyme granulates, enzyme granulates produced by the method, and the use thereof in formulations is provided, for example, for animal feed, foodstuffs, washing agents, rinsing agents or for pharmaceutical uses. The enzyme granulates have a high relative proportion of active enzyme, particular particle size, good shelf life, particularly small rounding factors and/or low resid...

The present invention relates to a two-component system for equipping surfaces with an oil, water, and dirt repellent coating, the two-component system being composed of a formulation 1 and a formulation 2, and both formulations being mixed together shortly before application. The invention further relates to a method of applying the two-component system to surfaces. The invention additionally rel...

The invention relates to a method for the in vitro titration of a non-conventional transmissible agent (NCTA), using transgenic cell lines. The invention also relates to: the application of the aforementioned in vitro titration method in a method for the in vitro evaluation and/or monitoring of the effectiveness of a biological production or treatment method or of one or more steps in such a metho...

The invention concerns a method for determining a concentration of hemoglobin in a sample of undiluted, unhemolyzed whole blood from a result of a first absorption measurement on the sample performed at a wavelength in the range 490 - 520 nm and a result of a second absorption measurement on the sample. The method comprises processing the results of the first and second absorption measurements to ...

A culture medium for filamentary fungi comprising at least one carbon source chosen from the group consisting of molasses, malt extract and sucrose and at least one organic nitrogen source chosen from yeast extract and corn steep liquor is described; a method for producing filamentary fungi, in particular nematophagus fungi on an industrial scale, comprising the step of seeding conidia of such fun...

Method involves adjusting rotational frequency of electric motor (1) at a constant value. An estimated value (FE) is calculated for the actuating force (F) and is compared with the predetermined limiting value. A current position of the actuating element is acquired near the predetermined limiting value and the current position is acquired at the final position, saved in the total stroke model. An...

The invention relates to the production of brea from distillates arising from high temperature coal tar having a distillation range of more than 260 °C, by means of sequential and combined application of three stages in mild pressure and temperature conditions (<400° C, <10 bar g), oxidative thermal treatment used as a reagent for air or oxygen, mixtures thereof, or air which is low in oxygen, the...

In a hearing device with low feedback tendency with simultaneous open feed and utilization of the natural directional effect of the pinna, the hearing device has a tube-shaped ear fitting piece for insertion into an auditory canal and speaker is arranged in the ear fitting piece, and at least two microphones are arranged in the ear fitting piece acoustically-symmetrically to the speaker in the bui...

The invention relates to the synthesis of boronic ester and acid compounds. More particularly, the invention provides improved synthetic processes for the large-scale production of the peptide boronic acid proteasome inhibitor bortezomib.

An insertion head for medical or pharmaceutical applications includes a base having a lower side positionable on organic tissue; an insertion means movably mounted by the base and insertable into the tissue; where the insertion means is movable relative to the base from a protective position in which a free end of the insertion means is short of the lower side of the base, into an insertion positi...

The present invention relates to methods for producing Saccharomyces strains that are capable of growth on xylose as a sole carbon source at a desired growth rate (such as at least one generation per 48 hours), strains made by such methods, and Saccharomyces strains that grow at a growth rate of at least one generation per 48 hours using xylose as a sole carbon source for growth made by non-recomb...

An arrangement in a planetary gearing includes a rotatable shaft connected to the planet wheel carrier of planet wheels, an internal gear and a sun wheel, wherein the planet wheels operatively engage by their coggings, i.e. mesh, with the outermost fixed-position cogging of the internal gear and with the centrally located cogging of the sun wheel. The power is transmitted from the sun wheel to the...

This invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.

The invention relates to the use of a phosphodiesterase type III (PDE III) inhibitor or Ca2+-sensitizing agent or a pharmaceutically acceptable derivative thereof for the preparation of a medication for the reduction of the heart size of a patient suffering from heart failure.

Cells present in processed lipoaspirate tissue are used to treat patients, including patients with renal conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external e...